Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with

Ramon J Whitson1, Marshall Scott Lucia, James R Lambert

  • 1Department of Pathology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado 80045, USA.

Insights

Growth differentiation factor-15 (GDF-15) directly interacts with connective tissue growth factor (CCN2), inhibiting CCN2-driven angiogenesis. This discovery reveals a novel GDF-15 signaling pathway potentially impacting cardiac disease, inflammation, and cancer.

Area of Science:

  • Molecular biology
  • Cell biology
  • Biochemistry

Background:

  • Growth differentiation factor-15 (GDF-15) and connective tissue growth factor (CCN2) are implicated in cardiac disease, inflammation, and cancer.
  • The precise roles and signaling mechanisms of GDF-15 and CCN2 in normal and diseased tissues are not fully understood.

Purpose of the Study:

  • To investigate the interaction between GDF-15 and CCN2.
  • To elucidate the functional consequences and molecular mechanisms of this interaction on angiogenesis.

Main Methods:

  • Yeast two-hybrid assays to detect protein interactions.
  • Biochemical pull-down assays to confirm direct binding.
  • In vitro angiogenesis assays using human umbilical vein endothelial (HUVEC) cells.
  • Examination of αV β3 integrin activation and focal adhesion kinase (FAK) signaling.

Main Results:

  • A direct interaction between GDF-15 and CCN2 was confirmed, localized to the von Willebrand factor type C domain of CCN2.
  • GDF-15 inhibited CCN2-mediated endothelial cell tube formation in vitro.
  • GDF-15 blocked CCN2-induced focal adhesion kinase (FAK) activation.
  • GDF-15 reduced αV β3 integrin clustering in HUVEC cells.

Conclusions:

  • This study demonstrates a novel signaling pathway where GDF-15 interacts with the matricellular protein CCN2.
  • GDF-15 antagonizes CCN2-mediated angiogenesis by inhibiting αV β3 integrin and FAK activation.
  • This interaction provides new insights into the role of GDF-15 in disease pathogenesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...